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By A . M . Sauter, W . Wiegrebe, and J . P . von Wartburg 
Summary: This work was initiated by the lack of a sensi-
tive method for the determination of disulfiram and its 
metabolites in blood of patients treated with this drug. A 
method is described which allows the separate determina-
tion of carbon disulfide, free diethyldithiocarbamate and 
disulfides derived from disulfiram with adequate precision 
in 10 ml patient blood. It is based on a spectrophotometric 
determination of a yellow compound formed by trapping 
carbon disulfide produced from diethyldithiocarbamate and 
disulfiram in an ethanolic solution of diethylamine and 
copper(II)-acetate. Good quantitation of disulfiram and 
diethyldithiocarbamate in blood was achieved by trapping 
carbon disulfide produced when formic acid and cystein 
were added to the samples. During daily administration of 
200 mg disulfiram to humans, concentrations of zero to 
0.6 [Ag carbon disulfide and 0.2 to 1.0 /ug diethyldithiocar-
bamate per ml blood were found using this method. 
Zusammenfassung: Nachweis von Disulfiram und seinen 
Metaboliten im menschlichen Blut 
Nach unserer Erfahrung gibt es keine Methode mit ausrei-
chender Empfindlichkeit, um Disulfiram und seine Meta-
boliten im Patientenblut zu bestimmen. Wir beschreiben 
ein Verfahren, mit dem CS2, Diäthyldithiocarbamat und 
vom Disulfiram stammende Disulfide getrennt mit hinrei-
chender Genauigkeit aus 10 ml Blut bestimmt werden kön-
nen. Grundlage ist die spektrophotometrische Bestimmung 
einer gelben Verbindung, die aus CS2 in einer äthanoli-
schen Lösung von Diäthylamin und Cu(II)-acetat entsteht. 
CS2 wird aus Diäthyldithiocarbamat und Disulfiram durch 
Ameisensäure bzw. Ameisensäure/Cystein freigesetzt. Bei 
Tagesdosen von 200 mg Disulfiram wurden 0 bis 0,6 /ug 
CS2 und 0,2 bis 1,0 jug Diäthyldithiocarbamat pro ml Pa-
tientenblut gefunden. 
1. Introduction 
Disulfiram (tetraethylthiuramdisulfide, T E T D , Antabus®*)) 
has become a popular drug for treatment of alcoholism 
since its discovery in 1948 [1]. It is usually administered 
p.o. in daily doses of 100—400 mg or implanted as tablets 
containing 1000—1600 mg. The absorption from the gastro-
intestinal tract seems to be incomplete, 5—20% appearing 
in the faeces [1—4]; nothing is known on the rate of ab-
sorption of implanted disulfiram. Scheme 1 represents the 
known metabolic pathways of disulfiram or its reduced 
form diethyldithiocarbamate ( D D C ) . Using 3 5S-labelled 
T E T D S t römme demonstrated the in vitro and in vivo 
formation of mixed disulfides with serum or liver proteins 
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Scheme 1: Main pathways of disulfiram metabolism. 
*) Manufacturer: E . Tosse & Co. mbH, Hamburg. 
[5—9]. N o free, unmetabolised T E T D could be detected 
by various authors in serum, liver or urine of experimental 
animals and man [1, 3, 7, 8]. After i.p. application to rats 
free D D C could be detected in serum only for a short time 
and mixed disulfides were formed with protein, indicating 
rapid interconversions between D D C , T E T D and mixed 
disulfides in vivo. T E T D and D D C are further metabolized 
to C S 2 [10, 11], sulfate [7, 10] and DDC-S-glucuronide 
[7, 12]. A significant part of administered T E T D is eli-
minated in expired air as C S 2 [10, 13]. 
In view of a wide-spread therapeutic use of disulfiram in 
general and an increased application of the implantation-
technique it was of interest to determine T E T D and its 
metabolites in patients. Several methods for the determina-
tion of disulfiram have been proposed [3, 14—16]. These 
methods rely on the formation of a yellow copper — T E T D 
— compound which is subsequently extracted with an or-
ganic solvent and determined photometrically. When these 
methods were applied to samples of human blood in our 
laboratory they proved to lack the necessary sensitivity. 
High blank values restrict their application to concentra-
tions of T E T D or D D C far above those expected in pa-
tients. Furthermore they do not account for the formation 
of mixed disulfides and C S 2 . Similar problems were encoun-
tered when we utilized the recently proposed colour-reac-
tion of T E T D with ethanol and cyanide [17]. Hence a 
method was developed which allows to determine C S 2 , free 
D D C and D D C liberated from disulfides (mixed disulfides 
and/or T E T D ) . 
2. Materials and methods 
A l l reagents were of the highest commercial grade from Fluka, 
Buchs, Switzerland, or Merck, Darmstadt, Germany, and used 
without further purification. The Viles-reagent was modified as 
follows: Cu(II)-acetate 0.1 g, diethylamine 35 g, triethanolamine 
10 g, demineralised water 75 ml, ethanol abs. ad 1000 ml. Excess 
solvent was removed by the use of a rotary evaporator Rota-
vapor Büchi, Flawil, Switzerland. Solutions were filtered with a 
syringe-filter apparatus from Sartorius (Göttingen, Germany) 
with solvent resistant and inert cellulose membrane filters S M 
11 604. The spectra were recorded on a Zeiss P M Q II and ab-
sorbances determined on a Unicam Sp 1800. 
3. Results and discussion 
3.1. Evaluation of published methods 
Previous methods [3, 14—16] to determine T E T D and 
D D C were based on the fact that these compounds form 
yellow complexes with cupric ions. Possible structures of 
these have been reported by Geldmacher et al. [18]. A l -
though the precise nature of these copper-addition com-
pounds is not yet known, they wi l l be referred to as cop-
per-complexes. F r o m their study these authors concluded 
that the complexes formed from D D C and T E T D cannot be 
distinguished on the bases of several physico-chemical para-
meters. A s shown in F i g . 1, identical spectra were obtained 
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Fig. 1: Spectra of disulfiram-, D D C - and CS2-copper complexes 
solvent: 85°/o ethanol containing 5X10~ 4M Cu-II-acetate. 
Identical spectra were obtained with 4X10" 5M disulfiram or8XlO~ 5 M 
DDC-Na. solvent; modified Viles reagent (cf. 2). Identical 
spectra were obtained with 4X10~5 M disulfiram, or 8X10 - 5 M D D C -
Na, or 8X10~5 M CS 2. The molar extinction coefficients £ were calcu-
lated assuming that 1 mole disulfiram forms 1 mole Cu-II-complex, 
while 2 moles DDC-Na or CS 2 form 1 mole Cu-II-complex. 
by the addition of copper(II)-acetate to D D C and T E T D 
in two solvent-systems. F o r the formation of the T E T D -
complex the samples were heated to 50° C for 15 min to 
enhance the rate of complex formation. A s reported pre-
viously [14, 18], two absorption maxima are observed at 
266 nm and 400 nm in ethanol with molar extinction coef-
ficients of 25 000 and 7200, respectively. The addition of 
diethylamine and triethanolamine leads to a shift of the 
second absorption maximum to 425 nm and increases the 
molar extinction coefficient to 10 300. Our results show 
that with the previous methods T E T D and D D C cannot 
be detected separately. Divatia et al. [14] observed that the 
extraction of the TETD-Cu-complex into dichlorethane is 
independent of the p H , while the extractability of the D D C -
Cu-complex decreases with increasing p H . Since this find-
ing could not be reproduced attempts were made to sepa-
rate the free compounds before formation of the copper 
complex. A s suggested by Domar et al. [3], D D C is ionized 
at p H 9 and should not be extractable with a lipophilic 
solvent in contrast to T E T D . Subsequent adjustment to an 
acid p H should allow extraction of D D C . Attempts to 
separate D D C and T E T D in this way failed because D D C 
was found to contaminate T E T D by approximately 30% 
at p H 9. Furthermore D D C decomposes to C S 2 and diethyl-
amine both in alkaline and acidic solution. Identification 
of T E T D by means of thin-layer chromatography has been 
proposed by Farago [16]. However, a separation and quan-
titation of T E T D and D D C could not be achieved by this 
technique. Al though the two compounds were separated 
with C H C 1 3 55, benzene 18, methanol 15, butanol 10, N H 3 
25% 2 (vol. parts) as solvent system, such a procedure 
could not be used for subsequent quantitation due to losses 
of D D C by decomposition. 
3.2. Determination of CS 2 and D D C 
Since C S 2 has been identified as a major metabolite of 
T E T D [10, 11, 13, 19] it seemed appropriate to establish 
a method for its determination in human blood. D D C de-
composes rapidly and quantitatively to C S 2 and diethyls-
amine in acidic solution and hence can be determined by 
measuring the C S 2 evolved [20—22]. A special apparatus 
was employed (Fig. 2) for this purpose. 
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Fig. 2: Apparatus employed for the determination of CS 2, D D C and 
disulfiram. 1: inlet for carrier-gas (nitrogen); 2: side flask containing 
formic acid; 3: reaction flask containing sample; 4: water cooling; 
5: glass tube with external spiral glassrod; 6: trap (test tube) contain-
ing reagent solution; 7: waterbath (50° C). 
The sample of citrated blood, serum or urine was diluted 
and placed in the reaction flask (for details cf. 3.6.1.). Free 
C S 2 was flushed with a stream of nitrogen from the reac-
tion flask and trapped with a reagent containing Cu(II)-
acetate, diethylamine, and triethanolamine [19]. The yellow-
coloured compound formed has a spectrum identical with 
those of the DDC-copper and TETD-coppe r complex (Fig. 
1). Furthermore, the same molar extinction coefficients 
were found on both absorption maxima. A n increase in 
concentration of diethylamine was necessary because the 
original composition of the reagent [23, 24] yielded a ma-
ximal colour intensity only after 20 min and the recovery 
of C S 2 was incomplete. In order to increase the sensitivity 
of the method, the content of the trap was transferred into 
a flask with ethanol and benzene and evaporated to dryness. 
The residue was taken up in methylacetate-acetone, be-
cause this solvent proved to give the highest colour yield. 
The copper complex was stable within the condition of 
this procedure and for at least 24 h at room temperature 
in solution. Absorbance was determined with 4 cm path-
length at 426 nm; measurements at 270 nm were less re-
liable because of high reagent blanks. A molar extinction 
coefficient of 13 120 was obtained by adding C S 2 directly 
to the reagent in the trap and using the procedure describ-
ed (see below). Hence, a concentration of 1 [Ag C S 2 / m l 
sample should yield an extinction corrected for reaction 
blank of 0.862. 
3.3. The calibration curve for CS 2 
A calibration curve for C S 2 was obtained by adding var-
ious amounts of C S 2 to 10 m l samples of urine, serum and 
blood (Fig. 3). The absorbance of 0.866 for a sample con-
centration of 1 /ug C S 2 / m l calculated from the slope of the 
calibration curve is in good agreement with the value ob-
tained from the molar extinction coefficient; these results 
indicate a full recovery of C S 2 added to blood, serum and 
urine in a range of 0.05 to 1.5 ^g /ml . 
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Fig. 3: Calibration curve for CS<*. Various amounts of CS 2 added to 
10 ml blood (•), serum (A) or urine (•) were analysed as mentioned 
in 3.6.1. The absorbance is corrected for the reagent blank, y = 
0.866 x + 0.014; R = 0.998. 
3.4. The calibration curve for D D C (Fig. 4) 
Various amounts of D D C were added to blood, serum and 
urine and the C S 2 evolved from the addition of formic acid 
was determined as described. One mole of C S 2 could be re-
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Fig. 4: Calibration curve for D D C . Various amounts of DDC-Na 
added to 10 ml blood (•), serum (A) or urine (•) were analysed as 
mentioned in 3.6.1. The absorbance is corrected for the reagent blank, 
y = 0.447 x — 0,006; R = 0,997. 
covered from one mole of D D C added to urine. However, 
recoveries varying between 30 to 80% were found with 
serum and virtually no C S 2 was liberated from D D C added 
to blood under these conditions. Since free D D C cannot 
form mixed disulfides it seems that it is oxydized to T E T D . 
B y addition of cystein to reduce disulfides full recovery was 
obtained. 1 jug C S 2 / m l is equivalent to 1.96 /ug D D C / m l . 
F o r this D D C concentration of 1.96 ^g /ml an extinc-
tion of 0.875 could be calculated from the slope of the 
calibration curve. This is in good agreement with the value 
obtained for C S 2 . 
3.5. The calibration curve for T E T D (Fig. 5) 
Cystein and formic acid were added to the samples of 
blood, serum and urine containing T E T D (Fig. 5). N o C S 2 -
formation was detectable without cystein, confirming that 
no reduction of T E T D took place. This method does not 
discriminate between T E T D and possibly formed mixed 
disulfides. Again good agreement was found between the 
slopes of the calibration curve for T E T D with that for C S 2 . 
Since it has to be considered that 2 moles C S 2 are formed 
from one mole of T E T D , 1 jug C S 2 / m l corresponds to 
1.95 fig T E T D / m l and yields an extinction of 0.850. 
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Fig. 5: Calibration curve for T E T D . Various amounts of T E T D ad-
ded to 10 ml blood (•), serum (A) or urine (•) were analysed as 
mentioned in 3.6.1. The absorbance is corrected for the reagent blank, 
y = 0.436 x — 0.002; R = 0.997. 
3.6. Determination of CS 2 , D D C and T E T D in the 
same sample 
Various amounts of all three compounds were added to 
water to yield mixtures within the range of concentrations 
used in the calibration curves. Free C S 2 was flushed and 
trapped in a first reagent solution. C S 2 subsequently liberat-
ed from D D C by addition of formic acid was captured in 
a new trap. Final ly the remaining T E T D was reduced with 
cystein and determined like D D C . A l l three compounds 
could be recovered separately within the accuracy obtained 
in the calibration curve. 
3.6.1. Procedure 
Mix 10 ml blood, serum or urine with 20 ml water and 0.1 ml 
n-octanol (antifoaming agent). Flush free CS 2 with N 2 at room 
temperature for 30 min with 100 ml N 2 per min. Trap the CS 2 
in 6 ml of the modified Viles reagent (see 2.). Transfer the yellow-
ish reagent solution into a flask and rinse the trap successively 
with 3 ml ethanol and 5 ml benzene. Evaporate the combined 
solution at 50° C and 15 Torr. Dissolve the residue in 2 ml of a 
mixture of methylacetate-acetone (7:3 vol.), filter and read the 
absorbance at 426 nm in 4 cm cuvettes using the solvent mixture 
as the reference. 
To determine free D D C and disulfides use a new trap with fresh 
reagent and add 5 ml formic acid and 0.1 g cystein-HCl. Heat 
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Fig. 6: Blood levels of TETD-metabolites. CS 2 and mixed-disulfide levels (expressed as DDC) in blood of 3 patients taking 200 mg of T E T D 
p.o. per day between 8 and 10 p.m. Blood was taken for analysis at 8 a.m. 
the sample to 50° C in a waterbath for 30 min. Determine the 
C S 2 evolved from D D C and disulfides as mentioned. A differen-
tiation between free D D C and disulfides ( T E T D and/or mixed 
disulfides) is possible by adding only formic acid at first liberat-
ing C S 2 from free D D C only. Subsequent addition of cystein 
liberates D D C from its disulfides. 
3.7. Within-day precision and recovery 
Table 1 shows the results of within-day estimates of preci-
sion and recovery for 3 different concentrations of D D C -
N a added to blood-samples and for reagent blanks obtained 
from different blood samples or water. The same values for 
the reagent blank were obtained when various blood samp-
les were used instead of water. The reagent blanks showed 
a relatively large variation but remained constant for one 
batch of reagents and for solutions stored for 2 weeks. A 
C V of 21 was found for a D D C - N a concentration of 0.1 
/ ig /ml blood. A t these low blood levels the method is l i -
Table 1: Within-day precision and recovery of D D C added to blood. 
All analyses were carried out as described under 3.6.1. The figures 
represent absorbance at 426 nm. a) RB water = Reagent blank with 
10 ml of distilled water. b) RB blood = Reagent blank with 10 ml of 
blood. Samples 1,2 and 3,4 = 2 blood conserves; samples 5,6 and 7,8 
= 2 fresh blood samples. c) DDC-Na was added to 10 ml of blood. A 
value of A = 0.123 was subtracted to correct for reagent blank. 
Sample RB1) RBb) DDC-Na concentration ,«g/ml
c) 
no. water blood 0.3 1.0 2.0 
1 0.118 0.126 0,087 0,267 0.567 
2 0,128 0.126 0.091 0.307 0.557 
3 0.120 0,122 0.091 0,307 0.577 
4 0.130 0,128 0.091 0.307 0.587 
5 0.124 0.110 0.096 0.297 0.567 
6 0.128 0,128 0,086 0,287 0.567 
7 0.126 0.120 0.096 0.287 0.557 
8 0,110 0.126 0.096 0,267 0.587 
Mean 0.123 0.123 0.092 0,291 0.571 
SD 0.007 0.006 0,004 0.017 0.012 
C V 5.7 4.9 4.3 5,8 2.1 
Recovery — — 105.3 100.1 97.2 
°/» 
Table 2: Recoveries of CS 2 and D D C added to various blood samples. 
4.2 iug of CS 2 and 25 ^g of DDC-Na were added to 10 ml of fresh 
blood. Both compounds were determined from the same sample. 
Blood sample CS 2 
No. Sex found («g/ml) 
recovery 
(°/o) 
found 
(.«g/ml) 
recovery 
(«Vo) 
1 M 0,44 105 2.6 104 
2 M 0,44 105 2.5 100 
3 F 0,42 lOiO 2.5 100 
4 F 0.44 105 2.4 96 
D D C 
mited by the large contribution of the blank to the absorb-
ance values of tests. Table 2 shows the good recovery of 
both C S 2 and D D C - N a added simultaneously to various 
blood samples. 
3.8. Analyses of patient blood 
In order to test the practicability of the method within the 
range of concentration of C S 2 and total D D C in the blood 
of patients, daily doses of 200 mg T E T D were administered 
between 8 and 10 p.m. to three individuals and blood was 
taken at 8 a.m. for analysis. The results are shown in F i g . 
6. CS 2-concentrations ranged from zero to 0.6 /^g/ml and 
DDC-concentrations from 0.2 to 1.0 ^g /ml . It is of interest 
to note that the CS 2-concentrations varied over a broad 
range simultaneously in all these subjects. Al though the 
reason for this phenomenon is not known, it seems to be of 
physiological origin, since experimental errors were exclud-
ed by analyses of standard solutions. 
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